Supriya Lifesci.

77
Buy
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE07RO01027
  • NSEID: SUPRIYA
  • BSEID: 543434
INR
930.80
14.25 (1.55%)
BSENSE

Jun 18

BSE+NSE Vol: 1.97 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 22.12% vs 23.73% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 50.77% vs 34.20% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -20.09% vs -31.58% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 57.80% vs 32.56% in Mar 2024

Compare Profit and Loss Results of Supriya Lifesci.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
781.00
71.00
710.00
1,000.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
85.00
0.00
85.00
0%
Net Sales
696.00
71.00
625.00
880.28%
Expenditure (Ex Depriciation)
Stock Adjustments
-21.00
0.00
-21.00
0%
Raw Materials Consumed
232.00
23.00
209.00
908.70%
Power & Fuel Cost
24.00
6.00
18.00
300.00%
Employee Cost
80.00
108.00
-28.00
-25.93%
Operating Expenses
50.00
24.00
26.00
108.33%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
34.00
0.00
34.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
12.00
4.00
8.00
200.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
435.00
399.00
36.00
9.02%
Operating Profit (PBDIT) excl Other Income
260.00
-327.00
587.00
179.51%
Other Income
9.00
1.00
8.00
800.00%
Operating Profit (PBDIT)
270.00
-325.00
595.00
183.08%
Interest
1.00
8.00
-7.00
-87.50%
Profit before Depriciation and Tax
268.00
-334.00
602.00
180.24%
Depreciation
20.00
10.00
10.00
100.00%
Profit Before Taxation & Exceptional Items
248.00
-345.00
593.00
171.88%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
248.00
-345.00
593.00
171.88%
Provision for Tax
60.00
0.00
60.00
0%
Profit After Tax
187.00
-345.00
532.00
154.20%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
600.00
-1,979.00
2,579.00
130.32%
Profit Available for appropriations
788.00
-2,324.00
3,112.00
133.91%
Appropriations
788.00
-2,324.00
3,112.00
133.91%
Equity Dividend (%)
50%
0%
50.00
Earnings Per Share
23.35
-10.64
33.99
319.45%
Profit And Loss - Net Sales
Net Sales 696.49 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 22.12% vs 23.73% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 260.80 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 50.77% vs 34.20% in Mar 2024

Profit And Loss - Interest
Interest 1.69 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -20.09% vs -31.58% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 187.96 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 57.80% vs 32.56% in Mar 2024